At the molecular level, the keratinocyte growth factor (KGF)/KGF receptor (KGFR) pathway has been identified as a dual therapeutic target for both epithelial repair and cancer regulation, offering potential in mucosal protection strategies during cancer treatment [18]. This evidence concerns the gene FGFR2 and cancer.